Abdelnoor Michael, Andersen Jack Gunnar, Arnesen Harald, Johansen Odd
Oslo Centre of Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway; Center for Clinical Heart Research, Department of Cardiology, Oslo University Hospital, Oslo, Norway.
Clinic of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway; Department of Health Management and Health Economics, Faculty of Medicine, University of Oslo, Oslo, Norway.
Vasc Health Risk Manag. 2017 Mar 20;13:101-109. doi: 10.2147/VHRM.S122951. eCollection 2017.
We aimed to summarize the pooled effect of early discharge compared with ordinary discharge after percutaneous coronary intervention (PCI) on the composite endpoint of re-infarction, revascularization, stroke, death, and incidence of rehospitalization. We also aimed to compare costs for the two strategies.
The study was a systematic review and a meta-analysis of 12 randomized controlled trials including 2962 patients, followed by trial sequential analysis. An estimation of cost was considered. Follow-up time was 30 days.
For early discharge, pooled effect for the composite endpoint was relative risk of efficacy (RRe)=0.65, 95% confidence interval (CI) (0.52-0.81). Rehospitalization had a pooled effect of RRe=1.10, 95% CI (0.88-1.38). Early discharge had an increasing risk of rehospitalization with increasing frequency of hypertension for all populations, except those with stable angina, where a decreasing risk was noted. Advancing age gave increased risk of revascularization. Early discharge had a cost reduction of 655 Euros per patient compared with ordinary discharge.
The pooled effect supports the safe use of early discharge after PCI in the treatment of a heterogeneous population of patients with coronary artery disease. There was an increased risk of rehospitalization for all subpopulations, except patients with stable angina. Clinical trials with homogeneous populations of acute coronary syndrome are needed to be conclusive on this issue.
我们旨在总结经皮冠状动脉介入治疗(PCI)后早期出院与普通出院相比,在再梗死、血运重建、中风、死亡以及再住院发生率等复合终点方面的综合效应。我们还旨在比较这两种策略的成本。
该研究是一项对12项随机对照试验进行的系统评价和荟萃分析,纳入了2962例患者,随后进行了试验序贯分析。考虑了成本估算。随访时间为30天。
对于早期出院,复合终点的综合效应为疗效相对风险(RRe)=0.65,95%置信区间(CI)(0.52 - 0.81)。再住院的综合效应为RRe = 1.10,95% CI(0.88 - 1.38)。对于所有人群,除稳定型心绞痛患者外,随着高血压发生率的增加,早期出院导致再住院风险增加,而在稳定型心绞痛患者中观察到风险降低。年龄增长会增加血运重建的风险。与普通出院相比,早期出院每位患者的成本降低了655欧元。
综合效应支持在治疗异质性冠心病患者群体时,PCI后安全使用早期出院。除稳定型心绞痛患者外,所有亚组的再住院风险均增加。需要针对急性冠状动脉综合征同质人群进行临床试验,才能对此问题得出结论。